Mabion confirmation (just google the word Mabion) multiple articles: “Novavax, Inc. (NVAX) - Says Signs Commercial Scale Production Deal With Novovax.
Says Total Value of Agreement is $372 Mln.
Says Deal to Run From 2022-2025.
Says Will Produce Antigene for Covid-19 Vaccine.
Says Deal is Unconditional and is Not Dependent on Vaccine Registration Procedures.
Says Deal is to Be Carried Out and Settled on a per Batch Basis for an Agreed Price per Series.
Says Commercial Scale Manufacturing in Gmp Standard to Start in Dec.”$Novavax(NVAX)$
精彩评论